Julie R. Gralow

Also affiliated with University of Washington, Fred Hutch Cancer Center

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 24 papers. Top paper: “Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial”.

Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial

The Lancet Oncology(2023)10.1016/s1470-2045(22)00739-2

N/A

2.0DataRank · unranked

102 citations

Priyanka Sharma, William E. Barlow, Julie R. Gralow, Shannon L. Puhalla, Carey K. Anders +16 more

Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast Cancer

New England Journal of Medicine(2019)10.1056/nejmoa1811714

N/A

0.729DataRank · unranked

128 citations

William E. Barlow, Kathy S. Albain, Ted A. Vandenberg, Shaker R. Dakhil, Nagendra R. Tirumali +7 more

Multimodal prediction of neoadjuvant treatment outcome by serial FDG PET and MRI in women with locally advanced breast cancer

Breast Cancer Research(2023)10.1186/s13058-023-01722-4

N/A

0.727DataRank · unranked

14 citations

Lanell M. Peterson, Isaac Jenkins, Alena Novakova-Jiresova, Hannah M. Linden, Julie R. Gralow +6 more

Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor–Positive, Early-Stage Breast Cancer

Journal of Clinical Oncology(2024)10.1200/jco.23.02344

N/A

0.646DataRank · unranked

17 citations

Jieling Miao, Lajos Pusztai, Matthew P. Goetz, Priya Rastogi, Patricia A. Ganz +17 more

Thymidine kinase activity levels in serum can identify HR+ metastatic breast cancer patients with a low risk of early progression (SWOG S0226)

Biomarkers(2023)10.1080/1354750x.2023.2168063

N/A

0.587DataRank · unranked

12 citations

Adrian Nordmark, Amy Williams, Costanza Paoletti, William E. Barlow, Erin F. Cobain +11 more

Results of a phase II randomized trial of cisplatin +/- veliparib in metastatic triple-negative breast cancer (TNBC) and/or germline BRCA-associated breast cancer (SWOG S1416).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.1001

N/A

0.587DataRank · unranked

49 citations

Eve T. Rodler, William E. Barlow, Julie R. Gralow, Shannon Leigh Huggins-Puhalla, Carey K. Anders +15 more

Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor–Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-1562

N/A

0.457DataRank · unranked

20 citations

William E. Barlow, Erin F. Cobain, Mattias Bergqvist, Rita S. Mehta, Julie R. Gralow +9 more

Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae314

N/A

0.443DataRank · unranked

10 citations

William E. Barlow, Julie R. Gralow, Funda Meric‐Bernstam, Kathy S. Albain, Daniel F. Hayes +19 more

Advancing Breast Cancer Advocacy in Eastern Europe and Central Asia: Findings From Women’s Empowerment Cancer Advocacy Network (WE CAN) Summits

JCO Global Oncology(2021)10.1200/go.20.00532

N/A

0.345DataRank · unranked

9 citations

Darya Kizub, Julie R. Gralow, Jo Anne Zujewski, Allison Dvaladze, Nicoleta Zenovia Antone

Couple Communication in Cancer: Protocol for a Multi-Method Examination

UNC Libraries(2022)10.17615/7kd5-8a56

N/A

0DataRank · unranked

0 citations

Brian Baucom, Donald H. Baucom, Katherine Ramos, Niall Bolger, Julie R. Gralow +16 more

Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer

JAMA Oncology(2020)10.1001/jamaoncol.2019.5559

N/A

0DataRank · unranked

78 citations

William E. Barlow, Reshma Jagsi, Thomas A. Buchholz, Steven Shak, Frederick L. Baehner +13 more

The challenge of measuring intra-individual change in fatigue during cancer treatment

UNC Libraries(2020)10.17615/c7jf-hg10

N/A

0DataRank · unranked

0 citations

Anthony L. Back, Deena R. Loeffler, Jimmy Hwang, Nan Rothrock, Bryce B. Reeve +12 more

Effect of Pretreatment Renal Function on Treatment and Clinical Outcomes in the Adjuvant Treatment of Older Women With Breast Cancer: Alliance A171201, an Ancillary Study of CALGB/CTSU 49907

UNC Libraries(2020)10.17615/8he8-0367

N/A

0DataRank · unranked

0 citations

Stuart M. Lichtman, Aminah Jatoi, Arti Hurria, Constance Cirrincione, Antonio C. Wolff +6 more

Advancing the care of individuals with cancer through innovation & technology: Proceedings from the cardiology oncology innovation summit 2020 and 2021

American Heart Journal Plus Cardiology Research and Practice(2023)10.1016/j.ahjo.2023.100354

N/A

0DataRank · unranked

4 citations

Craig J. Beavers, Brenton Bauer, Richard K. Cheng, Generika Berman, Catherine H. Marshall +52 more

Data from Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor–Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial

(2023)10.1158/1078-0432.c.6530384.v1

N/A

0DataRank · unranked

0 citations

William E. Barlow, Erin F. Cobain, Mattias Bergqvist, Rita S. Mehta, Julie R. Gralow +9 more

Data from Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor–Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial

(2023)10.1158/1078-0432.c.6530384

N/A

0DataRank · unranked

0 citations

William E. Barlow, Erin F. Cobain, Mattias Bergqvist, Rita S. Mehta, Julie R. Gralow +9 more

Comparing the prognostic and predictive utility of serum thymidine kinase 1 and CA 15-3 in patients with hormone receptor positive metastatic breast cancer starting first-line endocrine therapy in SWOG S0226.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.1076

N/A

0DataRank · unranked

0 citations

William E. Barlow, Costanza Paoletti, Mattias Bergqvist, Amy Williams, Hanna Ritzén +11 more

Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer [BIG 2-06/NCCTG N063D (Alliance)]

ESMO Open(2024)10.1016/j.esmoop.2024.103938

N/A

0DataRank · unranked

9 citations

M. Piccart-Gebhart, Shona Fielding, John Townend, D.W. Hillman, M. Colleoni +37 more

Predictive model of aromatase inhibitor non-adherence using patient-reported outcomes in women with breast cancer (SWOG S1105).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.12019

N/A

0DataRank · unranked

3 citations

Anna Moseley, Kathryn B. Arnold, Grace Clarke Hillyer, Julie R. Gralow, N. Lynn Henry +4 more

Race and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Positive Breast Cancer in the Randomized RxPONDER Trial

UNC Libraries(2025)10.17615/dgtt-ap31

N/A

0DataRank · unranked

0 citations

Julie R. Gralow, Edith Perez, Kevin Kalinsky, Gabriel N. Hortobágyi, Nancy U. Lin +19 more

Social support and its implications in older, early-stage breast cancer patients in CALGB 49907 (Alliance A171301): Social support in older breast cancer patients

UNC Libraries(2020)10.17615/wphq-zj46

N/A

0DataRank · unranked

0 citations

Aminah Jatoi, Ajeet Gajra, Julie R. Gralow, Antonio C. Wolff, Judith O. Hopkins +7 more

The Breast Health Global Initiative 2018 Global Summit on Improving Breast Healthcare Through Resource‐Stratified Phased Implementation: Methods and overview

Cancer(2020)10.1002/cncr.32891

N/A

0DataRank · unranked

129 citations

Allison Dvaladze, Anne F. Rositch, Ophira Ginsburg, Cheng Har Yip, Susan Horton +11 more

Patient-Reported Outcomes and Long-Term Nonadherence to Aromatase Inhibitors

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab022

N/A

0DataRank · unranked

26 citations

Alfred I. Neugut, Anna Moseley, Kathryn B. Arnold, Julie R. Gralow, N. Lynn Henry +4 more

Couple Communication in Cancer: Protocol for a Multi-Method Examination

Frontiers in Psychology(2022)10.3389/fpsyg.2021.769407

N/A

0DataRank · unranked

18 citations

Joan M. Romano, Francis J. Keefe, Donald H. Baucom, Timothy J. Strauman, Karen L. Syrjala +16 more